会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 75. 发明申请
    • NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES
    • 核酸,蛋白质和抗体
    • WO0226930A2
    • 2002-04-04
    • PCT/US0129838
    • 2001-09-25
    • HUMAN GENOME SCIENCES INCROSEN CRAIG ABIRSE CHARLES E
    • ROSEN CRAIG ABIRSE CHARLES E
    • C12N20060101C12N
    • C12N1/00
    • The present invention relates to novel proteins. More specifically, isolated nucleic acid molecules are provided encoding novel polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human polynucleotides and/or polypeptides, and antibodies. The invention further relates to diagnostic and thereapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to these novel polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting or enhancing the production and function of the polypeptides of the present invention.
    • 本发明涉及新型蛋白质。 更具体地,提供编码新型多肽的分离的核酸分子。 提供结合这些多肽的新型多肽和抗体。 还提供了载体,宿主细胞,以及用于产生人多核苷酸和/或多肽的抗体的重组和合成方法。 本发明还涉及用于诊断,治疗,预防和/或预测与这些新型多肽相关的疾病的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还涉及用于抑制或增强本发明多肽的产生和功能的方法和/或组合物。
    • 80. 发明申请
    • NUCLEIC ACIDS, PROTEINS, AND ANTIBODIES
    • 核酸,蛋白质和抗体
    • WO0155300A3
    • 2002-01-03
    • PCT/US0101238
    • 2001-01-17
    • HUMAN GENOME SCIENCES INCROSEN CRAIG ABARASH STEVEN CRUBEN STEVEN M
    • ROSEN CRAIG ABARASH STEVEN CRUBEN STEVEN M
    • C07K14/47C12N15/11
    • C07K14/47
    • The present invention relates to novel lung cancer related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as "lung cancer antigens", and the use of such lung cancer antigens for detecting disorders of the lung, particularly the presence of lung cancer and lung cancer metastases. More specifically, isolated lung cancer associated nucleic acid molecules are provided encoding novel lung cancer associated polypeptides. Novel lung cancer polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human lung cancer associated polynucleotides and/or polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the lung, including lung cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting the production and function of the polypeptides of the present invention.
    • 本发明涉及新的肺癌相关多核苷酸和由这些多核苷酸编码的多肽本文统称为“肺癌抗原”,以及使用这种肺癌抗原来检测肺部疾病,特别是肺癌和肺癌的存在 癌症转移。 更具体地,提供分离的肺癌相关核酸分子,其编码新的肺癌相关多肽。 提供了与这些多肽结合的新型肺癌多肽和抗体。 还提供载体,宿主细胞,以及用于产生人肺癌相关多核苷酸和/或多肽的重组和合成方法。 本发明还涉及用于诊断,治疗,预防和/或预后与肺相关的疾病(包括肺癌)和治疗这些疾病的治疗方法的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还涉及用于抑制本发明多肽的产生和功能的方法和/或组合物。